*ST长药
(300391)
| 流通市值：7.29亿 | | | 总市值：7.29亿 |
| 流通股本：3.50亿 | | | 总股本：3.50亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 21,744,583.09 | 9,918,488.59 | 9,012,776.1 | 8,296,536.14 |
| 应收票据及应收账款 | 897,822,994.9 | 990,759,257.8 | 1,023,063,349.86 | 980,553,203.98 |
| 其中：应收票据 | - | 0 | - | 636,228.97 |
| 应收账款 | 897,822,994.9 | 990,759,257.8 | 1,023,063,349.86 | 979,916,975.01 |
| 应收款项融资 | 117,057.8 | 1,301,744.16 | 96,575.7 | 222,168 |
| 预付款项 | 10,913,842.7 | 14,167,941.89 | 17,141,735.53 | 11,498,498.01 |
| 其他应收款合计 | 52,205,635.76 | 51,326,320.63 | 71,483,649.17 | 66,147,674.22 |
| 存货 | 85,741,647.33 | 55,931,649.49 | 46,773,287.62 | 42,450,996.74 |
| 合同资产 | 10,671,038.61 | 10,671,038.61 | 4,596,271.29 | 4,596,271.29 |
| 其他流动资产 | 13,076,751.15 | 15,978,727.07 | 12,462,190.12 | 15,592,070.73 |
| 流动资产合计 | 1,092,293,551.34 | 1,150,055,168.24 | 1,184,629,835.39 | 1,129,357,419.11 |
| 非流动资产: | | | | |
| 固定资产 | 611,878,959.44 | 619,459,558.73 | 625,646,989.67 | 632,215,922.55 |
| 在建工程 | - | - | - | 0 |
| 生产性生物资产 | - | - | - | 0 |
| 使用权资产 | 10,317.99 | 1,400,908.95 | 1,572,377.07 | 2,513,202.55 |
| 无形资产 | 75,944,198.44 | 76,425,964.5 | 76,911,530.56 | 77,506,356.64 |
| 商誉 | 16,368,263.14 | 16,368,263.14 | 16,368,263.14 | 16,368,263.14 |
| 长期待摊费用 | 127,098,729.65 | 130,799,540.25 | 137,367,727.53 | 137,723,358.13 |
| 递延所得税资产 | - | - | - | 0 |
| 其他非流动资产 | - | 0 | - | 33,120 |
| 非流动资产合计 | 831,300,468.66 | 844,454,235.57 | 857,866,887.97 | 866,360,223.01 |
| 资产总计 | 1,923,594,020 | 1,994,509,403.81 | 2,042,496,723.36 | 1,995,717,642.12 |
| 流动负债: | | | | |
| 短期借款 | 207,947,157.5 | 207,977,157.5 | 208,483,849.3 | 208,483,849.3 |
| 应付票据及应付账款 | 234,613,141.14 | 236,450,101.91 | 243,140,887.95 | 223,268,376.43 |
| 其中：应付票据 | 239,645.5 | 449,645.5 | 834,496.91 | 861,909.51 |
| 应付账款 | 234,373,495.64 | 236,000,456.41 | 242,306,391.04 | 222,406,466.92 |
| 合同负债 | 18,022,975.27 | 14,235,247.74 | 20,363,661.06 | 23,088,272.6 |
| 应付职工薪酬 | 24,368,935.09 | 25,635,989.34 | 27,656,623.7 | 28,779,268.39 |
| 应交税费 | 124,131,914.6 | 124,340,805.24 | 124,469,271.54 | 123,884,087.07 |
| 其他应付款合计 | 1,532,825,154.04 | 1,491,852,522.39 | 1,324,188,274.25 | 1,219,957,419.48 |
| 其中:应付利息 | 14,619,069.45 | 14,619,069.45 | 12,738,377.66 | 7,824,242.86 |
| 一年内到期的非流动负债 | 56,499,252.45 | 57,182,922.13 | 95,825,669.69 | 95,089,653.72 |
| 其他流动负债 | 1,551,007.15 | 1,851,255.57 | 1,064,562.89 | 2,093,902.42 |
| 流动负债合计 | 2,199,959,537.24 | 2,159,526,001.82 | 2,045,192,800.38 | 1,924,644,829.41 |
| 非流动负债: | | | | |
| 长期借款 | 375,248,273.94 | 375,248,273.94 | 444,399,000 | 444,399,000 |
| 租赁负债 | - | 787,436.3 | 1,399,069.21 | 1,387,586.84 |
| 预计负债 | 106,020 | 5,782,730.34 | 45,808,696.12 | 30,084,303.04 |
| 递延收益 | 14,669,466.38 | 14,751,266.39 | 14,833,066.4 | 14,914,866.41 |
| 递延所得税负债 | 1,180,792.65 | 1,231,170.85 | 1,595,995.97 | 1,595,995.97 |
| 其他非流动负债 | 46,082.76 | 46,082.76 | 19,672.57 | 46,082.76 |
| 非流动负债合计 | 391,250,635.73 | 397,846,960.58 | 508,055,500.27 | 492,427,835.02 |
| 负债合计 | 2,591,210,172.97 | 2,557,372,962.4 | 2,553,248,300.65 | 2,417,072,664.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 350,336,112 | 350,336,112 | 350,336,112 | 350,336,112 |
| 资本公积 | 788,172,222.03 | 788,172,222.03 | 788,172,222.03 | 788,172,222.03 |
| 盈余公积 | 18,358,424.24 | 18,358,424.24 | 18,358,424.24 | 18,358,424.24 |
| 未分配利润 | -1,799,439,574.1 | -1,706,061,200.53 | -1,650,519,734.61 | -1,589,707,417.48 |
| 归属于母公司股东权益合计 | -642,572,815.83 | -549,194,442.26 | -493,652,976.34 | -432,840,659.21 |
| 少数股东权益 | -25,043,337.14 | -13,669,116.33 | -17,098,600.95 | 11,485,636.9 |
| 股东权益合计 | -667,616,152.97 | -562,863,558.59 | -510,751,577.29 | -421,355,022.31 |
| 负债和股东权益合计 | 1,923,594,020 | 1,994,509,403.81 | 2,042,496,723.36 | 1,995,717,642.12 |
| 公告日期 | 2025-10-27 | 2025-08-26 | 2025-04-28 | 2025-04-21 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |